Trial site
Shenzhen university General Hospital
- 10running trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Lung cancer2 trials
- Thalassaemia2 trials
- Acute lymphoblastic leukaemia1 trial
- Coronary artery disease1 trial
- High blood pressure1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Early phase 11 trial
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting5 trials
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Shenzhen University General Hospital3 trials
- Janssen Research & Development, LLC2 trials
- Lepu Medical Technology (Beijing) Co., Ltd.2 trials
- Shenzhen Hemogen2 trials
- First Affiliated Hospital of Zhejiang University1 trial
Running trials
Recruiting
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML
Recruiting
To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension
Recruiting
Evaluating Safety and Efficacy of Lentiviral-transduced CD34+ HSCs in Β-thalassaemia Patients.
Recruiting
Not yet recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia3 recruiting
- Thalassaemia2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Coronary artery disease1 recruiting
- High blood pressure1 recruiting
- Pancreatic cancer1 recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026